Low and comparable rates of stent thrombosis found with zotarolimus- and sirolimus-eluting stents
Rates of stent thrombosis at three years were low and comparable between zotarolimus-eluting and sirolimus-eluting stents, according to findings from the PROTECT study described here today at ESC Congress 2012.
Aug 27, 2012
0
0